Literature DB >> 32953779

Whether immediate frozen-thawed embryo transfer improves IVF outcome in non-elective freeze all policy.

Loris Marin1, Amerigo Vitagliano1.   

Abstract

Entities:  

Year:  2020        PMID: 32953779      PMCID: PMC7475503          DOI: 10.21037/atm-2020-97

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
With the spread of vitrification techniques, the survival rate after thawing of embryos rapidly increased, reaching up to 90% for vitrified blastocysts (1). As a result of the advances in embryology laboratory techniques, the “segmentation” of in vitro fertilization (IVF)-embryo transfer cycles has been gradually introduced in the common practice as an alternative to fresh IVF for the protection of woman’s health and to improve the chances of implantation (2). Non-elective freeze all policy is currently indicated in case of unforeseeable complications occurring during controlled ovarian stimulation (COS) (e.g., unexpected hyper-response, hyperprogesteronemia, endometrial abnormalities) or before embryo transfer (i.e., patients’ fever and other illnesses). The principal question that remains unanswered concerns the optimal timing of frozen-thawed embryo transfer (FET) after COS. In this respect, the study by Huang et al. (3) heats up the debate on the possible advantages of immediate FET following non-elective freeze all cycles. In their retrospective study, the authors included 2,998 patients who underwent their first FETs after the first COS cycles using the non-elective freeze-all strategy. Patients were divided into the “immediate” group (i.e., FET performed within the first menstrual cycle after COS), and the “delayed” group where FET started after one or more menstrual cycles following COS. As a statistical solution to the problem of endogeneity between groups, the authors used the propensity score adjustment of confounders, thereby increasing between group comparability. After confounders adjustment, delayed FET after COS was associated with significantly decreased chances of clinical pregnancy (OR: 0.46–0.94), ongoing pregnancy (OR: 0.42–0.84) and live birth (OR: 0.42–0.85) than immediate transfer, as well as with higher risk of miscarriage (OR: 1.05–8.06). These interesting findings upon superiority of immediate transfer compared to delayed transfer were in line with one previous study (4), but contradicted other studies (5-10) that reported not significant differences between immediate and postponed embryo transfer. However, we cannot make direct inferences between studies as they applied different methodology (including differences in the protocols adopted and time intervals between oocyte retrieval and FET), and included patients with different characteristics. To the credit of Huang et al. (3), theirs was the largest cohort size among the studies on this topic. Moreover, the use of propensity score matching may have minimized the selection bias over conventional multivariable regression techniques, therefore providing robustness to their results. Although the results were exciting, the underlying mechanism for the association between earlier timing of FET and higher success at IVF need to be further investigated. Basing on the findings of the study by Huang et al. (3), it may be speculated that COS leaves a transient hormonal footprint with positive effects on endometrial receptivity. In this respect, the persistence of active corpora lutea following COS could enhance the circulating concentrations of several ovarian hormones, such as relaxin, during FET cycle (11). Alternatively, supraphysiologic hormonal stimulation during COS may positively modulate the expression of specific endometrial genes during the following menstrual cycle (12), similarly to what observed in women after endometrial mechanical stimulation (8,13). The findings by Huang et al. (3) are intriguing but not definitive. Observational data, even though analyzed with statistically efficient techniques, need to be confirmed by randomized controlled trials for proving cause-and-effects relationships between two phenomena. Therefore, future randomized controlled trials, with strict inclusion criteria and rigorous methodology, are urgently needed. Thanks to the efforts of Huang et al. from now on, immediate FET after COS can be considered as a valuable alternative to delayed FET. Until solid evidence will be available, physicians are advised to schedule FET based on clinical circumstances and after comprehensive patients’ consultation. The article’s supplementary files as
  13 in total

1.  Endometrial scratch injury for women with one or more previous failed embryo transfers: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Amerigo Vitagliano; Attilio Di Spiezio Sardo; Gabriele Saccone; Gaetano Valenti; Fabrizio Sapia; Mohan S Kamath; Mija Blaganje; Alessandra Andrisani; Guido Ambrosini
Journal:  Fertil Steril       Date:  2018-09       Impact factor: 7.329

2.  There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy.

Authors:  K Lattes; M A Checa; R Vassena; M Brassesco; V Vernaeve
Journal:  Hum Reprod       Date:  2016-12-16       Impact factor: 6.918

3.  Frozen embryo transfer can be performed in the cycle immediately following the freeze-all cycle.

Authors:  Kemal Ozgur; Hasan Bulut; Murat Berkkanoglu; Peter Humaidan; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2017-09-22       Impact factor: 3.412

4.  Frozen blastocyst transfer outcomes in immediate versus delayed subsequent cycles following GnRH agonist or hCG triggers.

Authors:  Leah Kaye; Audrey Marsidi; Puja Rai; Jeffrey Thorne; John Nulsen; Lawrence Engmann; Claudio Benadiva
Journal:  J Assist Reprod Genet       Date:  2018-01-03       Impact factor: 3.412

5.  Interval between IVF stimulation cycle and frozen embryo transfer: Is there a benefit to a delay between cycles?

Authors:  Chloe Higgins; Martin Healey; Sameer Jatkar; Beverley Vollenhoven
Journal:  Aust N Z J Obstet Gynaecol       Date:  2017-09-14       Impact factor: 2.100

6.  To delay or not to delay a frozen embryo transfer after a failed fresh embryo transfer attempt?

Authors:  Samuel Santos-Ribeiro; Johannie Siffain; Nikolaos P Polyzos; Arne van de Vijver; Lisbet van Landuyt; Dominic Stoop; Herman Tournaye; Christophe Blockeel
Journal:  Fertil Steril       Date:  2016-01-21       Impact factor: 7.329

7.  Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients.

Authors:  D Haouzi; S Assou; K Mahmoud; S Tondeur; T Rème; B Hedon; J De Vos; S Hamamah
Journal:  Hum Reprod       Date:  2009-02-26       Impact factor: 6.918

Review 8.  Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance.

Authors:  Laura Rienzi; Clarisa Gracia; Roberta Maggiulli; Andrew R LaBarbera; Daniel J Kaser; Filippo M Ubaldi; Sheryl Vanderpoel; Catherine Racowsky
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

9.  Delayed frozen embryo transfer failed to improve live birth rate and neonatal outcomes in patients requiring whole embryo freezing.

Authors:  Yuxia He; Haiyan Zheng; Hongzi Du; Jianqiao Liu; Lei Li; Haiying Liu; Mingzhu Cao; Shiping Chen
Journal:  Reprod Biol Endocrinol       Date:  2020-01-10       Impact factor: 5.211

10.  The interval between oocyte retrieval and frozen-thawed blastocyst transfer does not affect the live birth rate and obstetrical outcomes.

Authors:  Mathilde Bourdon; Pietro Santulli; Chloé Maignien; Khaled Pocate-Cheriet; Asim Alwohaibi; Louis Marcellin; Sarah Blais; Charles Chapron
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

View more
  1 in total

1.  Analysis of Relevant Factors Affecting the Pregnancy Rate of Frozen-Thawed Embryo Transfer Cycle.

Authors:  Ning Liu; Yuhong Wang; Jing Lu; Xihui Zhang; Yunjing Zhang; Haijun Zhao; Yijiao Zhang; Wenliang Chang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-18       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.